Dynavax Technologies Corp (DVAX)
12.36
+0.19
(+1.56%)
USD |
NASDAQ |
Nov 21, 16:00
12.38
+0.02
(+0.12%)
After-Hours: 20:00
Dynavax Technologies Price to Book Value: 2.384 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 2.384 |
| November 20, 2024 | 2.348 |
| November 19, 2024 | 2.317 |
| November 18, 2024 | 2.255 |
| November 15, 2024 | 2.355 |
| November 14, 2024 | 2.583 |
| November 13, 2024 | 2.608 |
| November 12, 2024 | 2.604 |
| November 11, 2024 | 2.635 |
| November 08, 2024 | 2.510 |
| November 07, 2024 | 2.319 |
| November 06, 2024 | 2.371 |
| November 05, 2024 | 2.317 |
| November 04, 2024 | 2.272 |
| November 01, 2024 | 2.271 |
| October 31, 2024 | 2.284 |
| October 30, 2024 | 2.325 |
| October 29, 2024 | 2.276 |
| October 28, 2024 | 2.195 |
| October 25, 2024 | 2.064 |
| October 24, 2024 | 2.076 |
| October 23, 2024 | 2.095 |
| October 22, 2024 | 2.118 |
| October 21, 2024 | 2.116 |
| October 18, 2024 | 2.111 |
| Date | Value |
|---|---|
| October 17, 2024 | 2.105 |
| October 16, 2024 | 2.126 |
| October 15, 2024 | 2.074 |
| October 14, 2024 | 2.016 |
| October 11, 2024 | 2.010 |
| October 10, 2024 | 1.982 |
| October 09, 2024 | 2.041 |
| October 08, 2024 | 2.049 |
| October 07, 2024 | 2.076 |
| October 04, 2024 | 2.124 |
| October 03, 2024 | 2.157 |
| October 02, 2024 | 2.188 |
| October 01, 2024 | 2.178 |
| September 30, 2024 | 2.147 |
| September 27, 2024 | 2.242 |
| September 26, 2024 | 2.212 |
| September 25, 2024 | 2.196 |
| September 24, 2024 | 2.216 |
| September 23, 2024 | 2.265 |
| September 20, 2024 | 2.314 |
| September 19, 2024 | 2.344 |
| September 18, 2024 | 2.285 |
| September 17, 2024 | 2.295 |
| September 16, 2024 | 2.273 |
| September 13, 2024 | 2.277 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.982
Minimum
Oct 10 2024
83.73
Maximum
Jun 26 2020
11.35
Average
4.680
Median
Price to Book Value Benchmarks
| Biogen Inc | 1.408 |
| Repligen Corp | 3.938 |
| West Pharmaceutical Services Inc | 8.444 |
| Janux Therapeutics Inc | 3.720 |
| XOMA Royalty Corp | 4.180 |
Price to Book Value Related Metrics
| PE Ratio | 95.08 |
| PS Ratio | 6.740 |
| Price to Free Cash Flow | 77.54 |
| Price | 12.36 |
| Earnings Yield | 1.05% |
| Market Cap | 1.625B |
| Normalized PE Ratio | 95.08 |